Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The role of stromal and immune cells in atrial disease

ABSTRACT: The role of stromal and immune cells in atrial disease

PROVIDER: PRJNA933179 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18151700.fastq.gz	Fastqsanger.gz
	SRR18151701.fastq.gz	Fastqsanger.gz
	SRR18151702.fastq.gz	Fastqsanger.gz
	SRR18151703.fastq.gz	Fastqsanger.gz
	SRR18151704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 136

Similar Datasets

The role of stromal and immune cells in atrial disease [III]

Project description:The role of stromal and immune cells in atrial disease [III]

| PRJNA937016 | ENA

The role of stromal and immune cells in atrial disease [II]

Project description:The role of stromal and immune cells in atrial disease [II]

| PRJNA933166 | ENA

The role of stromal and immune cells in atrial disease [I]

Project description:The role of stromal and immune cells in atrial disease [I]

| PRJNA810732 | ENA

The role of stromal and immune cells in atrial disease [II]

Project description:In atrial fibrillation, disturbed electrical conduction disrupts the coordinated contraction of the heart’s antechambers, increasing the risk of stroke and heart failure. The rising prevalence of this disease approaches 9% in patients >65 years. Studying freshly isolated human atrial tissue and a new mouse model, we here decipher how immune and stromal cells contribute to the structural tissue remodeling that underlies atrial fibrillation. Single-cell transcriptomes from control and diseased human atria documented macrophage doubling at the expense of endothelial and mural cells. An inflammatory monocyte and a pro-fibrotic SPP1+ macrophage cluster expanded in patients with atrial fibrillation. To experimentally perturb pathways observed in patients, we matched their risk factors Hypertension, Obesity and Mitral valvE Regurgitation (HOMER) in mice. Atrial single-cell transcriptomes obtained in HOMER mice, which developed enlarged, fibrillation-prone atria, recapitulated human cell composition and transcriptome variations. Recruitment drove the expansion of atrial macrophages; accordingly, inhibition of monocyte migration reduced arrhythmia in Ccr2-/- HOMER mice. Deleting Spp1 established macrophage-derived osteopontin as a pleiotropic signal that promotes atrial fibrillation through pro-fibrotic, inflammatory crosstalk with an arsenal of local immune and stromal cells. Taken together, we identify SPP1+ macrophages as targets for immunomodulatory therapy in atrial fibrillation.

2023-07-13 | GSE224947 | GEO

The role of stromal and immune cells in atrial disease [III]

2023-07-13 | GSE225671 | GEO

The role of stromal and immune cells in atrial disease [I]

2023-07-13 | GSE197518 | GEO

Comparison of atrial appendage tissues of patients with Valvular Heart Disease and patients with Valvular Heart Disease-Atrial Fibrillation

Project description:Atrial fibrillation (AF) is the most common heart arrhythmia disease. The greatest risk of atrial fibrillation is stroke, and stroke caused by valvular heart disease with atrial fibrillation (AF-VHD) is more serious. the development mechanism from VHD to AF-VHD is not yet clear. The research on expression profiles of lncRNA and mRNA is helpful to explore molecular mechanism in patients with valvular heart disease who develop atrial fibrillation.

2018-04-12 | GSE113013 | GEO

Reduced TBX5 dosage causes human atrial disease by undermining developmental gene regulation of atrial cardiomyocyte identity [scATAC-seq]

Project description:In a TBX5-linked human cellular model of atrial disease, we examined the gene networks controlled by TBX5 during human atrial differentiation using single-cell RNA and ATAC sequencing.

2025-12-01 | GSE285168 | GEO

Reduced TBX5 dosage causes human atrial disease by undermining developmental gene regulation of atrial cardiomyocyte identity [scRNA-seq]

2025-02-18 | GSE285169 | GEO

The role of stromal and immune cells in atrial disease

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-07-13 | GSE224959 | GEO